RCEL

#3143
Avita Medical, Inc. Common Stock
5.03
+1.62%
Sector:
Base:
Profit Currency:
Daily Range
5.03
5.03
Year Range
3.22
10.29
Daily Change
+1.62%
Monthly Change
+11.04%
6 month change
+11.28%
Year Change
-43.74%
Previous Close
4.95
Open
5.03
Bid
Ask
Low
5.03
High
5.03
Volume
37
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
  • Market Capitalization 140.14 M
  • Employee 226
  • Founded 1999
  • CEO James Corbett
  • Website www.avitamedical.com
  • Headquarter Delaware, United States
  • FIGI BBG00TD18T43
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-1.98
Price to sales ratio
1.34
Dividends per share
—
Dividend yield %
—

Avita Medical Inc

Avita Medical is a clinical and commercial company developing and marketing a range regenerative medicine products. The first regenerative medicine product brought to the market by Avita Medical was ReCell spray-on skin for the treatment of burns. The two latest products are ReNovaCell, for Aesthetics and Plastic applications including skin trauma, and ReGenerCell for the treatment of chronic wounds. The Avita Medical regenerative product range is currently marketed in Europe, the Middle East, Africa and Australia.

News